Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00953641

Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Saskatchewan · Academic / Other
Sex
Female
Age
35 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether using Misoprostol vaginally before an office endometrial biopsy is performed, will make it easier, more successful and less painful to do the procedure. The investigators' hypothesis is that vaginal Misoprostol 12 hours prior to endometrial biopsy will increase the ease of performing office endometrial biopsy by reducing the need to use a tenaculum or a cervical dilator to achieve passage of a biopsy pipelle.

Detailed description

Endometrial biopsy is a common gynecological office procedure performed to assist in the pathological diagnosis of abnormal vaginal bleeding. The procedure can be painful and it may be difficult to obtain an endometrial sample with a hard and closed cervix. Giving Misoprostol before the procedure may soften the cervix sufficiently to allow an easier and more successful test. This medication has been tested before hysteroscopy and in some patients it has been shown to be beneficial. 104 patients need to be recruited for this study. Participants will be divided according to pre-menopausal and post-menopausal status. Each of these groups will then be divided into a treatment arm (with Misoprostol) and a placebo arm. Participants will place a vaginal suppository containing either Misoprostol 400 ug or a placebo 12h or more before their appointment for the endometrial biopsy.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostolMisoprostol 400ug, suspended in a base (Witepsol 15) as a vaginal suppository Single dose 12h or more prior to the procedure
DRUGPlaceboWitepsol 15 base, vaginal suppository, Single dose, 12h or more prior to the endometrial biopsy

Timeline

Start date
2011-09-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2009-08-06
Last updated
2012-08-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00953641. Inclusion in this directory is not an endorsement.